Research output per year
Research output per year
Research output
Search results
-
2021
Biosimilar to biosimilar infliximab switching in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry: Switch from originator infliximab to CT-P13 and then to GP1111
Nabi, H., Glintborg, B., Loft, A., Hendricks, O., Pedersen, J., Just, S., Ahmed, R., Danebod, K., Munk, H., Colic, A., Linauskas, A., Jensen, D. V., Raun, J., Grydehøj, J., Christensen, L., Manilo, N., Lomborg, N., Kristensen, S., Mehnert, F. & Krogh, N. & 1 others, , 2021, In: Arthritis and Rheumatology. 73, No. S9, p. 1161-3 3 p., 0573.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
Multiple infliximab biosimilar switches: Results following a nationwide switch from originator infliximab to biosimilar CT-P13, and subsequently to biosimilar GP1111, in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry
Nabi, H., Glintborg, B., Loft, A., Hendricks, O., Pedersen, J., Just, S., Ahmed, R., Danebod, K., Munk, H., Colic, A., Linauskas, A., Jensen, D. V., Christensen, L., Manilo, N., Lomborg, N., Kristensen, S., Mehnert, F., Krogh, N. & Hetland, M. L., 2021, In: Scandinavian Journal of Rheumatology, Supplement. 50, 130, p. 14-5 2 p., OP16.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review